These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21458079)

  • 21. Direct cleavage, proteasomal degradation and sequestration: three mechanisms of viral subversion of type I interferon responses.
    McInerney GM; Karlsson Hedestam GB
    J Innate Immun; 2009; 1(6):599-606. PubMed ID: 20375615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response.
    Oganesyan G; Saha SK; Guo B; He JQ; Shahangian A; Zarnegar B; Perry A; Cheng G
    Nature; 2006 Jan; 439(7073):208-11. PubMed ID: 16306936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding inhibition of viral proteins on type I IFN signaling pathways with modeling and optimization.
    Zou X; Xiang X; Chen Y; Peng T; Luo X; Pan Z
    J Theor Biol; 2010 Aug; 265(4):691-703. PubMed ID: 20553733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-alpha production by swine dendritic cells is inhibited during acute infection with foot-and-mouth disease virus.
    Nfon CK; Ferman GS; Toka FN; Gregg DA; Golde WT
    Viral Immunol; 2008 Mar; 21(1):68-77. PubMed ID: 18355124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Innate recognition of viruses.
    Pichlmair A; Reis e Sousa C
    Immunity; 2007 Sep; 27(3):370-83. PubMed ID: 17892846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutting Edge: TLR-Dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells.
    Kumagai Y; Kumar H; Koyama S; Kawai T; Takeuchi O; Akira S
    J Immunol; 2009 Apr; 182(7):3960-4. PubMed ID: 19299691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility to virus infection is determined by a Stat-mediated response to the autocrine effect of virus-induced type I interferon.
    Improta T; Pine R
    Cytokine; 1997 Jun; 9(6):383-93. PubMed ID: 9199872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs.
    Solórzano A; Webby RJ; Lager KM; Janke BH; García-Sastre A; Richt JA
    J Virol; 2005 Jun; 79(12):7535-43. PubMed ID: 15919908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple mechanisms contribute to impairment of type 1 interferon production during chronic lymphocytic choriomeningitis virus infection of mice.
    Lee LN; Burke S; Montoya M; Borrow P
    J Immunol; 2009 Jun; 182(11):7178-89. PubMed ID: 19454715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights into type I interferon and the immunopathogenesis of persistent viral infections.
    Snell LM; Brooks DG
    Curr Opin Immunol; 2015 Jun; 34():91-8. PubMed ID: 25771184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of double-stranded RNA and Npro of classical swine fever virus in the activation of monocyte-derived dendritic cells.
    Bauhofer O; Summerfield A; McCullough KC; Ruggli N
    Virology; 2005 Dec; 343(1):93-105. PubMed ID: 16154171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous detection of porcine circovirus type 2, classical swine fever virus, porcine parvovirus and porcine reproductive and respiratory syndrome virus in pigs by multiplex polymerase chain reaction.
    Jiang Y; Shang H; Xu H; Zhu L; Chen W; Zhao L; Fang L
    Vet J; 2010 Feb; 183(2):172-5. PubMed ID: 19131259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The importance of being a pDC in antiviral immunity: the IFN mission versus Ag presentation?
    Haeryfar SM
    Trends Immunol; 2005 Jun; 26(6):311-7. PubMed ID: 15922947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural interferon-alpha producing cells: the plasmacytoid dendritic cells.
    Fitzgerald-Bocarsly P
    Biotechniques; 2002 Oct; Suppl():16-20, 22, 24-9. PubMed ID: 12395924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Image-based study of interferongenic interactions between plasmacytoid dendritic cells and HSV-infected monocyte-derived dendritic cells.
    Megjugorac NJ; Jacobs ES; Izaguirre AG; George TC; Gupta G; Fitzgerald-Bocarsly P
    Immunol Invest; 2007; 36(5-6):739-61. PubMed ID: 18161527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How opportunistic agents benefit from viral infections: the plasmacytoid dendritic cell connection.
    Baranek T; Dalod M
    Cell Host Microbe; 2008 Oct; 4(4):305-7. PubMed ID: 18854232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of plasmacytoid DC: Roles in disease pathogenesis and targets for immunotherapy.
    Swiecki M; Colonna M
    Eur J Immunol; 2010 Aug; 40(8):2094-8. PubMed ID: 20853492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type I interferons: diversity of sources, production pathways and effects on immune responses.
    Swiecki M; Colonna M
    Curr Opin Virol; 2011 Dec; 1(6):463-75. PubMed ID: 22440910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The multifaceted biology of plasmacytoid dendritic cells.
    Swiecki M; Colonna M
    Nat Rev Immunol; 2015 Aug; 15(8):471-85. PubMed ID: 26160613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host responses to alphavirus infection.
    Ryman KD; Klimstra WB
    Immunol Rev; 2008 Oct; 225():27-45. PubMed ID: 18837774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.